XML 57 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED BALANCE SHEETS (USD $)
Jan. 31, 2014
Jul. 31, 2013
Jul. 31, 2012
Jan. 31, 2014
Series A Convertible Preferred Stock
Jul. 31, 2013
Series A Convertible Preferred Stock
Jul. 31, 2012
Series A Convertible Preferred Stock
Jan. 31, 2014
Series B Convertible Preferred Stock
Jul. 31, 2013
Series B Convertible Preferred Stock
Jul. 31, 2012
Series B Convertible Preferred Stock
Jan. 31, 2014
Series C Convertible Preferred Stock
Jul. 31, 2013
Series C Convertible Preferred Stock
Jul. 31, 2012
Series C Convertible Preferred Stock
Jan. 31, 2014
Series D Convertible Preferred Stock
Jul. 31, 2013
Series D Convertible Preferred Stock
Jul. 31, 2012
Series D Convertible Preferred Stock
Jan. 31, 2014
Series E Convertible Preferred Stock
Jul. 31, 2013
Series E Convertible Preferred Stock
Jul. 31, 2012
Series E Convertible Preferred Stock
ASSETS                                    
Cash and cash equivalents $ 3,141,212 $ 1,708,954 $ 246,309                              
Other current assets 102,428 98,315 200,552                              
Total Current Assets 3,243,640 1,807,269 446,861                              
Property and Equipment, Net (Note 3) 16,440 85,406 704,678                              
Assets Held for Investment, Net (Note 3)    640,772 858,377                              
Patents, Net (Note 4) 2,163,696 2,319,416 2,634,458                              
TOTAL ASSETS 5,423,776 4,852,863 4,644,374                              
LIABILITIES AND STOCKHOLDERS' (DEFICIENCY)/EQUITY                                    
Accounts payable and accrued expenses (Note 6) 7,891,679 7,661,234 7,015,652                              
Deferred revenue 223,662 224,843 263,125                              
Current maturities of long-term debt (Note 8)    617,665 1,222,746                              
Total Current Liabilities 8,115,341 8,503,742 8,501,523                              
Long-Term Debt, Net (Note 8)       441,415                              
Derivative Warrant Liability (Note 10) 5,259,929 5,234,293 4,081,627                              
Derivative Additional Investment Rights Liability (Note 10) 126,195 1,256,160                                 
Total Liabilities 13,501,465 14,994,195 13,024,565                              
Stockholders' Deficiency (Notes 9 and 11):                                    
9% Convertible Preferred Stock                                                      
Common stock, $.001 par value; authorized 1,500,000, 1,500,000,000 and 750,000,000 shares at October 31, July 31, 2013 and 2012, respectively;611,314,230, 580,329,160 and 354,161,297 issued and outstanding at October 31, 2013, July 31, 2013 and 2012, respectively 696,050 580,329 354,161                              
Additional paid-in capital 361,399,963 356,401,812 348,099,813                              
Deficit accumulated during the development stage (370,953,051) (367,888,576) (357,611,780)                              
Accumulated other comprehensive income 779,349 765,103 777,615                              
Total Stockholders' Deficiency (8,077,689) (10,141,332) (8,380,191)                              
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY $ 5,423,776 $ 4,852,863 $ 4,644,374